Drugs that contain Defibrotide Sodium
1. List of Defitelio drug patents
DEFITELIO's oppositions filed in EPO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11236328 | JAZZ PHARMS INC | Euglobulin-based method for determining the biological activity of defibrotide |
Jun, 2032
(9 years from now) | |
| US11085043 | JAZZ PHARMS INC | Euglobulin-based method for determining the biological activity of defibrotide |
Jun, 2032
(9 years from now) | |
Do you want to check out DEFITELIO patents from before 2022?
| Exclusivity | Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity (ODE) | Mar 30, 2023 |
Market Authorisation Date: 30 March, 2016
Treatment: Treatment of adult and pediatric patients with hepatic veno-occlusive disease (vod), also known as sinusoidal obstruction syndrome (sos), with renal or pulmonary dysfunction following hematopoietic st...
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
DEFITELIO family patents
6
United States
4
Korea, Republic of
2
China
1
Italy
1
Spain
1
Russia
1
Hong Kong
1
Brazil
1
Israel
1
Canada
1
Singapore
1
India
1
Mexico
1
Japan
1
Australia
1
Denmark
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic